Cargando…
Unraveling DPP4 Receptor Interactions with SARS-CoV-2 Variants and MERS-CoV: Insights into Pulmonary Disorders via Immunoinformatics and Molecular Dynamics
Human coronaviruses like MERS CoV are known to utilize dipeptidyl peptidase 4 (DPP4), apart from angiotensin-converting enzyme 2(ACE2) as a potential co-receptor for viral cell entry. DPP4, the ubiquitous membrane-bound aminopeptidase, is closely associated with elevation of disease severity in como...
Autores principales: | Roy, Arpan Narayan, Gupta, Aayatti Mallick, Banerjee, Deboshmita, Chakrabarti, Jaydeb, Raghavendra, Pongali B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612102/ https://www.ncbi.nlm.nih.gov/pubmed/37896834 http://dx.doi.org/10.3390/v15102056 |
Ejemplares similares
-
Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants
por: Gupta, Aayatti Mallick, et al.
Publicado: (2020) -
DPP4-directed therapeutic strategies for MERS-CoV
por: Reinhold, Dirk, et al.
Publicado: (2014) -
Adaptive Evolution of MERS-CoV to Species Variation in DPP4
por: Letko, Michael, et al.
Publicado: (2018) -
The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
por: Li, Yu, et al.
Publicado: (2020) -
The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
por: Li, Yu, et al.
Publicado: (2020)